http://www.editasmedicine.com
Editas Medicine, Inc. Company Intro
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Industry
Healthcare
Editas Medicine, Inc. Headquaters
11 Hurley Street
Cambridge,02141
United States
Editas Medicine, Inc. Share price
23 Oct 2020 01:31 GMT
$30.40
0.13 (0.43 %)
Editas Medicine, Inc. Market cap
$2.009 B
WMC RANKING
2020
Editas Medicine, Inc. # 103
BiotechnologyLatest Editas Medicine, Inc. News
23 Oct 2020
Covid-19 Impact on Global CRISPR & Cas Genes Market Insights, Forecast to 2026 | CRISPR Therapeutics, AstraZeneca, Addgene
Editas Medicine, Inc. Egenesis F. Hoffmann-La Roche Ltd. Horizon Discovery Group Plc Genscrip Danaher Corporation Intellia Therapeutics, Inc. Lonza
23 Oct 2020
Gene Editing Market Growth with Challenges, Standardization ...
... Therapeutics, Editas Medicine, EMD Millipore (Merck KGaA), GeneCopoeia, GenScript Corporation, Horizon Discovery Ltd, Integrated DNA Technologies Inc, ...
23 Oct 2020
Global CRISPR Genome Editing Market To Show Startling ...
Editas Medicine, CRISPR Therapeutics AG, Horizon Discovery PLC., ... England Biolabs Inc, Origene Technologies Inc., Transposagen Biopharmaceuticals, ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Editas Medicine, Inc. | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.22 | 100 | 19 | 0 | 0 | 98.82 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.11 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.25 | 100 | 0 | 0 | 90.92 |
Editas Medicine, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Editas Medicine, Inc. | $14,366 | $142,119 | $-121,031 | $2.009B | 103 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.228B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $54.719B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.699B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.79B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Editas Medicine, Inc. Social Followers vs Top 4 Industry Competitors
Editas Medicine, Inc. Post vs Top 4 Industry Competitors
Book a demo
A free one-on-one demo with one of our team and see exactly what the WMC business intelligence platform can do for your organisation.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
